Please email us at Sales@AmericanPharmaWholesale.com with our item No, NDC#,UPC#or best is product link. We are located in Oceanside, California. Search over 100,000 items by Name, Item No., NDC, UPC (without dashes) or by Mfg.Name.
Menu

Saizen 8.8mg Vial by Serono Labs

NDC 44087-1088-01 UPC/GTIN No.3-44087-10881-6 Mfg.Part No.108801Serono Labs, Inc.This Item Can Only Be Ordered By A Drug Mfg, Wholesaler,Pharmacy,Physician, Dentist, Podiatrist, Optometrist,Veterinarian,Naturopath,Licensed Lab, Physical Therapist & Pharmacist(scope).Serono Labs, Inc.Image 4 of Saizen 8.8mg Vial by Serono Labs

Saizen 8.8mg Vial by Serono Labs

$1080.40$969.00

NDC No. 44087-1088-01 UPC/GTIN No. 3-44087-10881-6 MPN 108801 Only Physician,Pharmacy or Licensed Facility can order this Rx Item No. Rx868307 Saizen 8.8mg Vial by Serono Labs, Item No. 3868307 NDC No. 44087108801 UPC No. 344087108816 Other Name Saizen, SOMATROPIN Therapeutic Code 682800 Therapeutic Class Pituitary Item Class Non Controlled Rx. Case Qnty: 96 Therapeutic Code 682800 Pituitary Info Pituitary Common Group Somatropin Sub-Q Vial 8.8 Unit Dose Packaging? Item Form Inj If You Are A Pat

Have a question?

SAIZEN somatropin
SAIZEN CLICKEASY somatropin
SAIZENPREP- somatropin
EMD Serono, Inc.
1 INDICATIONS AND USAGE
1.1 Pediatric Patients

SAIZEN [somatropin (rDNA origin) for injection] is indicated for the treatment of pediatric patients with growth failure due to inadequate secretion of endogenous growth hormone.
1.2 Adult Patients

SAIZEN is indicated for replacement of endogenous growth hormone in adults with growth hormone deficiency who meet either of the following two criteria:

Adult Onset

Patients who have growth hormone deficiency, either alone or associated with multiple hormone deficiencies (hypopituitarism), as a result of pituitary disease, hypothalamic disease, surgery, radiation therapy, or trauma; or

Childhood Onset

Patients who were growth hormone deficient during childhood as a result of congenital, genetic, acquired, or idiopathic causes.

Patients who were treated with somatropin for growth hormone deficiency in childhood and whose epiphyses are closed should be reevaluated before continuation of somatropin therapy at the reduced dose level recommended for growth hormone deficient adults. Confirmation of the diagnosis of adult growth hormone deficiency in both groups involves an appropriate growth hormone provocative test with two exceptions: (1) patients with multiple other pituitary hormone deficiencies due to organic disease; and (2) patients with congenital/genetic growth hormone deficiency.
2 DOSAGE AND ADMINISTRATION

For subcutaneous injection.

SAIZEN therapy should be supervised by a physician who is experienced in the diagnosis and management of pediatric patients with growth hormone deficiency or adult patients with either childhoodonset or adult-onset growth hormone deficiency.

NDC 44087-1088-01 UPC/GTIN No.3-44087-10881-6 Mfg.Part No.108801
Saizen 8.8mg Vial by Serono Labs
NDC 44087-1088-01 UPC/GTIN No.3-44087-10881-6 Mfg.Part No.108801

Serono Labs, Inc.

Serono Labs, Inc.

This Item Can Only Be Ordered By A Drug Mfg, Wholesaler,Pharmacy,Physician, Dentist, Podiatrist, Optometrist,Veterinarian,Naturopath,Licensed Lab, Physical Therapist & Pharmacist(scope).
SOMATROPIN SUB-Q VIAL 8.8
This Item Can Only Be Ordered By A Drug Mfg, Wholesaler,Pharmacy,Physician, Dentist, Podiatrist, Optometrist,Veterinarian,Naturopath,Licensed Lab, Physical Therapist & Pharmacist(scope).

Serono Labs, Inc.
Serono Labs, Inc.

Image 4 of Saizen 8.8mg Vial by Serono Labs